-Search query
-Search result
Showing 1 - 50 of 253 items for (author: laughlin & t)
EMDB-29950:
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21B10
Method: single particle / : Patel A, Ortlund EA
EMDB-29975:
Overall map of SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21B10
Method: single particle / : Patel A, Ortlund EA
EMDB-40007:
Local map of SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21B10
Method: single particle / : Patel A, Ortlund EA
EMDB-28913:
SARS-CoV-2 spike glycoprotein trimer bound with two nanobodies
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28914:
SARS-CoV-2 spike glycoprotein trimer bound with two nanobodies (locally-refined)
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28930:
SARS-CoV-2 spike glycoprotein trimer with nanobody bound to RBD in "up" conformation
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28931:
SARS-CoV-2 spike glycoprotein trimer with nanobody bound to RBD in the "up" conformation (locally-refined)
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28868:
Overall, original map of SARS-CoV-2 spike glycoprotein trimer with RBDs in the down conformation with nanobody attached to two RBDs.
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28880:
Locally refined map of SARS-CoV-2 spike glycoprotein trimer with nanobody bound to two RBDs
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28856:
SARS-CoV-2 spike protein trimer (down conformation) bound with a nanobody
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
PDB-8f4p:
SARS-CoV-2 spike protein trimer (down conformation) bound with a nanobody
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28688:
SARS-CoV-2 spike protein bound with a nanobody
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
PDB-8eyh:
SARS-CoV-2 spike protein bound with a nanobody
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-28686:
SARS-CoV-2 spike protein complexed with two nanobodies
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
PDB-8eyg:
SARS-CoV-2 spike protein complexed with two nanobodies
Method: single particle / : Laughlin ZT, Patel A, Ortlund EA
EMDB-18448:
CTE type II (tau intermediate amyloid)
Method: helical / : Lovestam S, Scheres SHW, Goedert M
PDB-8qjj:
CTE type II (tau intermediate amyloid)
Method: helical / : Lovestam S, Scheres SHW
EMDB-18112:
Tau - AD-MIA4
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18252:
Tau - AD-LIA4 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18253:
Tau - AD-LIA5 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18254:
Tau - AD-LIA7 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18255:
Tau - AD-PHF long crossover
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18258:
Tau - AD-PHF
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18259:
Tau - AD-THF
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18261:
Tau - CTE-MIA1 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18262:
Tau - CTE-MIA3
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18263:
Tau - CTE-MIA4 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18264:
Tau - CTE-MIA5 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18265:
Tau - CTE-MIA6 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18266:
Tau - CTE-MIA7 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18270:
Tau - CTE-MIA9 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18271:
Tau - CTE-MIA8 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18272:
Tau - CTE-MIA10 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18273:
Tau - CTE-MIA11 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18275:
Tau - CTE-MIA13 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18276:
Tau - CTE-MIA14 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18277:
Tau - CTE-MIA15 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18278:
Tau - CTE-MIA18 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18281:
Tau - CTE-LIA4 (tau intermediate amyloid)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18344:
AD Tau intermediate amyloid (LIA-1)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18347:
AD Tau intermediate amyloid (LIA-3)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18348:
AD Tau intermediate amyloid (MIA-9)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18349:
AD Tau intermediate amyloid (QHF)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18354:
CTE Tau intermediate amyloid (MIA-2)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18355:
CTE Tau intermediate amyloid (MIA-16)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18356:
CTE Tau intermediate amyloid (MIA-19)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18357:
CTE Tau intermediate amyloid (MIA-20)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18358:
CTE Tau intermediate amyloid (LIA-1)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18359:
CTE Tau intermediate amyloid (LIA-2)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
EMDB-18360:
CTE Tau intermediate amyloid (LIA-8)
Method: helical / : Lovestam S, Li D, Scheres SHW, Goedert M
Pages: